C. elegans: A novel pharmacogenetic model to study Parkinson's disease

Parkinsonism and Related Disorders

Volumn 7, Issue 3, 2001, Pages 185-191

  Nass, R ^a   Miller III, D M ^a   Blakely, R D ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

6 OHDA; Apoptosis; Dopamine; Genetics; MPP+; Necrosis; Nematode; Neurodegeneration; Transporter

Indexed keywords

COCAINE; DEXAMPHETAMINE; DNA FRAGMENT; DOPAMINE TRANSPORTER; IMIPRAMINE; NEUROTOXIN; NISOXETINE; VANOXERINE;

ANIMAL MODEL; CAENORHABDITIS ELEGANS; CONFERENCE PAPER; DOPAMINERGIC SYSTEM; HUMAN; MOLECULAR CLONING; NERVE DEGENERATION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEQUENCE HOMOLOGY;

EID: 0035028904     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1353-8020(00)00056-0     Document Type: Conference Paper

References (56)

1. Oxidative mechanisms in nigral cell death in Parkinson's disease
2. Mechanism of action of 6-hydroxydopamine
3. Mechanism of action of 6-hydroxydopamine neurotoxicity
4. +: uptake and toxicity in nonneuronal COS cells expressing dopamine transporter cDNA
5. Dopamine transporter expression confers cytotoxicity to low doses of the Parkinsonism-inducing neurotoxin 1-methyl-4-phenylpyridinium
6. Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: uptake of the metabolite N-methyl-4-pheynylpyridine by dopamine neurons explains selective toxicity
7. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter
8. Re-evaluation of the role of the dopamine transporter in dopamine system homeostasis
9. Genome sequence of the nematode C. elegans: a platform for investigating biology
10. Introduction to C. elegans
11. The structure of the nervous system of the nematode Caenorhabditis elegans
12. Green fluorescent protein as a marker for gene expression
13. LIN-10 is a shared component of the polarized protein localization pathways in neurons and epithelia
14. Two-color GFP expression for C. elegans
15. Serotonin-deficient mutants and male mating behavior in the nematode Caenorhabditis elegans
16. Patterning of dopaminergic neurotransmitter identity among Caenorhabditis elegans ray sensory neurons by a TGFβ family signaling pathway and a Hox gene
17. The cat-1 gene of Caenorhabditis elegans encodes a vesicular monoamine transporter required for specific monoamine-dependent behaviors
18. The Caenorhabditis elegans gene T23G5.5 encodes an antidepressant- and cocaine-sensitive dopamine transporter
19. The C. elegans genome sequencing project: a beginning
20. Neurobiology of the Caenorhabditis elegans genome
21. Differential expression of tyrosine hydroxylase in catecholaminergic neurons of neonatal wild-type and Nurr1-deficient mice
22. Reduced Nurr1 expression increases the vulnerability of mesencephalic dopamine neurons to MPTP-induced injury
23. Dopaminergic neurons in the nematode Caenorhabditis elegans
24. C. elegans locomotory rate is modulated by the environment through a dopaminergic pathway and by experience through a serotonergic pathway
25. Genetic analysis of dopaminergic neurons in the nematode Caenorhabditis elegans
26. Post-embryonic cell lineages of the nematode Caenorhabditis elegans
27. Sensory regulation of male mating behavior in Caenorhabditis elegans
28. Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter
29. Molecular characterization of the dopamine transporter
30. Ultrastructual view of central catecholaminergic transmission: immunocytochemical localization of synthesizing enzymes, transporters, and receptors
31. Immunogold localization of the dopamine transporter: an ultrastructural study of the rat ventral tegmental area
32. Distinct mechanisms underlie neurotoxin-mediated cell death in cultured dopaminergic neurons
33. Dopamine transporters and neuronal injury
34. Extrachromosomal DNA transformation of Caenorhabditis elegans
35. Features of the dopaminergic neurotoxin MPTP
36. The generation of hydrogen peroxide, superoxide radical, and hydroxyl radical by 6-hydroxydopamine, dialuric acid, and related cytotoxic agents
37. Autooxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine and related compounds toward C1300 neuroblastoma cells in vitro
38. Is Parkinson's disease (PD) an extra-mitochondrial disorder?
39. +-induced dopaminergic neuronal cell death: role of caspases, ROS, and JNK
40. Transgenic mice expressing human Bcl-2 in their neurons are resistant to 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity
41. Overexpression of HA-Bax but not Bcl-2 or Bcl-XL attenuates 6-hydroxydopamine-induced neuronal apoptosis
42. Morphology of programmed cell death in the ventral nerve cord of Caenorhabditis elegans
43. Neuropathology of degenerative cell death in Caenorhabditis elegans
44. Neuronal apoptosis in acute necrotic insults: why is this subject such a mess?
45. Genetic control of programmed cell death in the nematode C. elegans
46. Caenorhabditis elegans gene ced-9 protects cells from programmed cell death
47. 6-OHDA sensitivity of dopaminergic